Last reviewed · How we verify
MDD diagnosis and Estrogen treatment
MDD diagnosis and Estrogen treatment is a Small molecule drug developed by University of Pennsylvania. It is currently FDA-approved.
At a glance
| Generic name | MDD diagnosis and Estrogen treatment |
|---|---|
| Sponsor | University of Pennsylvania |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- MDD diagnosis and Estrogen treatment CI brief — competitive landscape report
- MDD diagnosis and Estrogen treatment updates RSS · CI watch RSS
- University of Pennsylvania portfolio CI
Frequently asked questions about MDD diagnosis and Estrogen treatment
What is MDD diagnosis and Estrogen treatment?
MDD diagnosis and Estrogen treatment is a Small molecule drug developed by University of Pennsylvania.
Who makes MDD diagnosis and Estrogen treatment?
MDD diagnosis and Estrogen treatment is developed and marketed by University of Pennsylvania (see full University of Pennsylvania pipeline at /company/university-of-pennsylvania).
What development phase is MDD diagnosis and Estrogen treatment in?
MDD diagnosis and Estrogen treatment is FDA-approved (marketed).